Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00012 in active rheumatoid arthritis
NCT00810836Phase 2Completed
- Sponsor
- Biogen
- Start
- Dec 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of dimethyl fumarate in rheumatoid arthritis (RA), sponsored by Biogen. Started Dec 2008; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00810836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810836.